ZBTB20 promoted HCC cell viability, proliferation, tumorigenicity and cell cycle progression by directly suppressing FoxO1, and subsequently up-regulated Cyclin D1/Cyclin E and down-regulated p21/p27. Here, ZBTB20 is linked to hepatocellular carcinoma.